Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Trk-IN-4

🥰Excellent
Catalog No. T17169Cas No. 1799788-94-5
Alias PF-6683324

Trk-IN-4 (PF-6683324) is a potent pan-Trk inhibitor with IC50 = 1.1~2.6 nM for TrkA/TrkB/TrkC and antinociceptive effects. It is also a selective type II PTK6 inhibitor with IC50 = 76 nM and has antitumor effects.

Trk-IN-4

Trk-IN-4

🥰Excellent
Purity: 98.13%
Catalog No. T17169Alias PF-6683324Cas No. 1799788-94-5
Trk-IN-4 (PF-6683324) is a potent pan-Trk inhibitor with IC50 = 1.1~2.6 nM for TrkA/TrkB/TrkC and antinociceptive effects. It is also a selective type II PTK6 inhibitor with IC50 = 76 nM and has antitumor effects.
TargetMol
Product information is being updated, if you want to purchase, please click the bulk custom button.
Bulk & Custom
Questions
View More
Select Batch
Purity:98.13%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Trk-IN-4 (PF-6683324) is a potent pan-Trk inhibitor with IC50 = 1.1~2.6 nM for TrkA/TrkB/TrkC and antinociceptive effects. It is also a selective type II PTK6 inhibitor with IC50 = 76 nM and has antitumor effects.
Targets&IC50
K+ channel (hERG):14 μM, TrkC:1.1 nM, TrkA:1.9 nM, TrkB:2.6 nM
In vitro
Trk-IN-4 is a potent pan-Trk inhibitor with cellular IC₅₀ values of 1.9 nM (TrkA), 2.6 nM (TrkB), and 1.1 nM (TrkC), showing high kinase selectivity and low hERG liability (IC₅₀ = 14 μM), with favorable lipophilic efficiency (LipE = 5.7)[1].
In vivo
Trk-IN-4 showed significant antinociceptive activity in a rat UV burn hyperalgesia model at oral doses of 0.03-3 mg/kg, with maximal effects at 3 mg/kg. Trk-IN-4 demonstrated good oral bioavailability (52%), low clearance, and peripheral restriction (Cb,u/Cp,u = 0.043), supporting its use as a pain therapeutic with minimal CNS side effects[1].
AliasPF-6683324
Chemical Properties
Molecular Weight521.46
FormulaC24H23F4N5O4
Cas No.1799788-94-5
SmilesO(C1=C(C(N)=O)C=C(C=N1)C=2N=CN(C)C2)[C@@H]3[C@H](F)CN(C(CC4=CC=C(OC(F)(F)F)C=C4)=O)CC3
Relative Density.1.46 g/cm3 (Predicted)
Storage & Solubility Information
Storagestore at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice./Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (153.42 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.9177 mL9.5885 mL19.1769 mL95.8846 mL
5 mM0.3835 mL1.9177 mL3.8354 mL19.1769 mL
10 mM0.1918 mL0.9588 mL1.9177 mL9.5885 mL
20 mM0.0959 mL0.4794 mL0.9588 mL4.7942 mL
50 mM0.0384 mL0.1918 mL0.3835 mL1.9177 mL
100 mM0.0192 mL0.0959 mL0.1918 mL0.9588 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Sci Citations

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Trk-IN-4 | purchase Trk-IN-4 | Trk-IN-4 cost | order Trk-IN-4 | Trk-IN-4 chemical structure | Trk-IN-4 in vivo | Trk-IN-4 in vitro | Trk-IN-4 formula | Trk-IN-4 molecular weight